The success rate of fixed dose radioiodine therapy is about 70% and how increasing it Graves disease success rate of fixed dose of radioiodine therapy
Conditions
Interventions
Graves diseases in EEC were treated with radioiodine therapy protocol 1,Graves diseases in EEC were treated with radioiodine therapy protocol 2
Treatment,Treatment
The treatment of radioiodine therapy protocol 1,The treatment of radioiodine therapy protocol 2
Sponsors
Queen Savang Memorial Vadhana Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. the patient was diagnosed as Graves disease and getted indication for radioiodine therapy including thyroid strom, thyrotoxicosis periodic paralysis, side effects from anti-thyroid drugs and relapse ,recurrent or incomplete remission of Graves disease. 2. No contraindication for radioiodine therapy including pregnancy, lactation, moderate-to-severe Graves opthalmopathy. 3. patient hadn't been treated with radioiodine therapy.
Exclusion criteria
Exclusion criteria: 1. loss-to-follow up is less than 5 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of The treatment of fixed dose radioiodine therapy 5-6 months Euthyroidism or Hypothroidism from Thyroid function test | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of The treatment of fixed dose radioiodine therapy 12 months Euthyroidism or Hypothroidism from Thyroid function test,Comparison between incidence of hypothyroidism after fixed dose radioiodine therapy protocal 1 and protocal 2 12 months Hypothroidism from Thyroid function test,The Failure factor of Protocol 2 fixed dose radioiodine therapy 12 months Baseline characteristic in Protocol 2 | — |
Countries
Thailand
Contacts
Public ContactYoswanich Maiprasert
Queen Savang Memorial Hospital
Outcome results
None listed